DOSEID
DEAD

Serial Number

90019323

Owner

Kit Check, Inc.

Attorney

Gregory B. Phillips

Filing Date

Jun 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

DOSEID Trademark

Serial Number: 90019323

DOSEID is a trademark filed by Kit Check, Inc. on June 24, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

Kit Check, Inc. (12 trademarks)

803 7th Street NW, Suite 350
Washington, DC 20001

Entity Type: 03

Trademark Details

Filing Date

June 24, 2020

Registration Date

Not Registered

Goods & Services

Computer software licensing; Licensing of intellectual property rights

Providing temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing authentication and verification services using computer hardware and software for pharmaceuticals, medical dispensing systems, and medical supplies; Developing and maintaining a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Feb 4, 2021 MAB1
ABANDONMENT - EXPRESS MAILED
Feb 4, 2021 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Feb 3, 2021 EXAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 29, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2020 NWOS
NEW APPLICATION ENTERED
Jun 27, 2020 NWAP